- ￥2181 - 5280
- MedChemExpress(MCE)
- 美国
- HY-112284
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
OBE022
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
2005486-31-5
- 规格：
10 mM * 1 mL/1 mg/5 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥5280.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥2181.0 |
| 规格： | 5 mg | 产品价格： | ￥4800.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Ebopiprant
CAS No. : 2005486-31-5
MCE 国际站：Ebopiprant
产品活性：Ebopiprant (OBE022) 是一个口服的、前列腺素 F2α (PGF2α) 受体的选择性拮抗剂，其对人和大鼠 FP 受体的 Ki 值分别为 1 nM 和 26 nM。
研究领域：GPCR/G Protein
作用靶点：Prostaglandin Receptor
In Vitro: Ebopiprant (OBE022) and OBE002 are assayed for FP binding affinity by competitive binding analysis with 3H-PGF2α using HEK293 cells stably transfected with the FP receptor. Binding affinities (Ki) of OBE022 for the human and rat FP receptor are 1 nM and 26 nM respectively. For OBE002, Kis are 6 nM for the human and 313 nM for the rat FP receptor. The binding of both OBE022 and OBE002 is reversible and competitive since increasing concentrations of either compound causes successive decreases in the slope of the binding curves, consistent with an increase in equilibrium dissociation constant (KD) without a reduction in receptor density.
In Vivo: Time-course of the cumulative percentage of delivers mice after RU486-induced preterm parturition at GD17, in OBE022, nifedipine or vehicle treatment groups. Oral treatment with OBE022 delays the preterm birth caused by RU486 administration as reflected by a shift to the right of the percentage of delivery curve. The effect of oral treatment with nifedipine is comparable. Both OBE022 and nifedipine show a trend to increase the time of first pup delivery. As an important consequence of the prolongation of gestation, dams deliver viable pups. Combination of OBE022 and nifedipine cause a synergistic effect on the delay of RU486-induced preterm birth as reflected by a more pronounced shift to the right of the percentage of delivery curve, in comparison to OBE022 or nifedipine alone. Also, a larger increase of the time of first pup delivery is observed.
相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Endocrinology Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Prostaglandin E2 | EIPA | Prostaglandin E1 | Tranilast | PF-04418948 | U-46619 | Iloprost | Prostaglandin D2 | ONO-AE3-208 | Dinoprost | Palupiprant | Latanoprost | Selexipag | 16,16-Dimethyl prostaglandin E2 | Treprostinil | DG-041 | Grapiprant | L-798106 | GW627368 | Fevipiprant | Asapiprant | AH 6809 | L-161982 | Laropiprant | Bimatoprost | CJ-42794 | MF498 | Beraprost sodium | Ramatroban
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
